If you follow the headlines, it feels like both the best and worst times for scientists. 

In the United States, numerous research projects have been canceled or frozen, and scientists seeking new grants face unprecedented political pressure. 

At the same time, the display of humanoid robots at China’s popular Spring Festival Gala signal that the country’s massive investment in science is paying off. 

China’s progress is increasingly framed as a challenge to American leadership in research and innovation. This framing reinforces institutional beliefs that efficiency should be prioritized over exploration.

As the U.S. government increasingly frames research funding through the lens of geopolitical competition, the U.S. model is beginning to look like China’s: more centralized priorities, defined national targets, and measurable short-term returns. 

Researchers are responding accordingly. Grant applications are trending towards politically safe and discrete topics perceived as more likely to secure funding. 

This approach may be pragmatic. But before the U.S. leaps to follow China’s model of scientific funding, it should examine how similar pressures have reshaped China’s scientific system.

China’s Focus on Efficiency over Exploration

Having worked in both Chinese and U.S. research environments, I have seen the strengths and vulnerabilities of each. 

Over the past decade, China’s scientific rise — driven and supported by government efforts to catch up with global peers — has been extraordinary. Massive state investment, centralized coordination, and clearly defined national priorities have propelled rapid gains in publications, patents, and global rankings. The scale and speed are historic, reminiscent of the country’s sharp economic ascent. 

China’s progress is increasingly framed as a challenge to American leadership in research and innovation. This framing reinforces institutional beliefs that efficiency should be prioritized over exploration. Resources are directed toward politically defined priorities and measurable outputs, and research increasingly reflects short-term incentives rather than long-horizon inquiry. 

The cumulative pressure has reshaped scientific culture in China and intensified peer competition. 

In China’s scientific ecosystem, funding allocations, institutional prestige, and career advancement are tightly linked to government priorities and to quantifiable outputs such as publication counts, impact factors, and citation indices. Researchers are pushed to meet those requirements by publishing more papers each year, submitting more grant applications, and operating on accelerated timelines, often at the expense of deeper scientific exploration. 

The cumulative pressure has reshaped scientific culture in China and intensified peer competition. 

The thresholds required to secure federal research grants continue to rise. In such an environment, sustaining long-term innovation and research integrity becomes increasingly difficult. Rising retractions of Chinese publications in recent years reflect strains within this incentive architecture. 

More concretely, it’s not clear these investments are paying dividends. 

Downstream, less than 4% of university research outputs in China are estimated to translate into industrial product launches, much lower than in most industrialized countries. This gap suggests that evaluation systems that heavily reward research productivity do not necessarily produce proportional societal or economic returns.  

Does Efficiency Work?

The impact also extends beyond research itself and is particularly visible in academic medicine in China. 

Biomedical research has attracted substantial government investment, and major hospitals have become research hubs. But when a physician’s prospects for promotion are closely tied to publication output, clinical responsibilities compete with academic productivity. Time and attention that should be devoted to patient care are redirected toward academic production. It is no coincidence that both workload and burnout among Chinese physicians are much higher than in the U.S. and many Western countries. 

Competition should not compromise the core scientific values of long-term exploration, intellectual independence, and ethical guardrails. 

At the same time, publication pressure has caused some clinical trials conducted in China to demonstrate weaker adherence to global norms and established reporting standards, raising concerns about the independence and accountability of Chinese research. Consequently, the likelihood that these trials will lead to improved patient outcomes may be limited. 

Of course, these dynamics are not uniquely Chinese. Even before the recent funding shifts, similar tendencies were emerging in the U.S. 

For example, as residency programs increasingly emphasize research skills, the resulting pressure of publish-or-perish drives medical students to prioritize publications at the expense of patient-focused training in order to differentiate themselves and secure competitive slots. 

In contrast, physicians who devote more time to clinical duty are associated with better patient outcomes. 

What the Recent Funding Cuts Might Do to U.S. Science

Still, the U.S. has historically benefited from a different model than the one China is pursuing: decentralized peer review, investigator-driven grants, tolerance for intellectual risk, and institutional autonomy. 

The recent funding cuts and politicized topic preferences risk pushing research to follow political signals rather than scientific merit. This inclination toward what is politically popular may gradually reshape the scientific system itself.  

The question for U.S. policymakers is not how to match another nation’s output curve. It is whether the U.S. can preserve the structural conditions that allow science to flourish across generations.

As geopolitical competition intensifies, it is understandable that policymakers may feel an urgency to prioritize national interests, define strategic targets, and measure outputs more aggressively. 

But competition should not compromise the core scientific values of long-term exploration, intellectual independence, and ethical guardrails. 

Decades of U.S. scientific prosperity were underpinned by the postwar architecture shaped by MIT scientist Vannevar Bush’s 1945 proposal to President Franklin D. Roosevelt, which decentralized scientific decision-making from direct political control. It was this structural trust, rather than sheer output volume, that built the modern research ecosystem. The question for U.S. policymakers is not how to match another nation’s output curve. It is whether the U.S. can preserve the structural conditions that allow science to flourish across generations.